ZTS

ZOETIS
D

ZTS

164.300
USD
-4.48
(-2.65%)
مغلق
حجم التداول
131,913
الربح لكل سهم
6
العائد الربحي
1.12
P/E
30
حجم السوق
73,147,683,108
التوصيات
Moustafa El khaldy
Moustafa El khaldy
منذ 11 شهر
buy
ZTS
ZTS@174.98
2024-07-08 03:45
ZTS@174.98 Chart
الربح
877.00
المزيد
أصول ذات صلة
AMGN
AMGN
-2.10
(-0.70%)
295.22 USD
BMRN
BMRN
-1.000
(-1.75%)
56.220 USD
E
ELAN
-0.365
(-2.57%)
13.815 USD
GILD
GILD
-2.080
(-1.86%)
110.010 USD
IDXX
IDXX
-4.11
(-0.78%)
522.78 USD
INCY
INCY
-1.490
(-2.15%)
67.750 USD
MRK
MRK
-0.050
(-0.06%)
81.740 USD
REGN
REGN
7.50
(1.44%)
529.39 USD
VRTX
VRTX
-4.36
(-0.95%)
455.70 USD
المزيد
الأخبار المقالات

العنوان: ZOETIS

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.